stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Free cash flow margin
Neogen Corporation's free cash flow margin over the twelve months to 31 August 2026 was 5.64%, up 2.0 percentage points from fiscal 2026 (3.68%). Over the past ten years it has ranged from −8.22% (fiscal 2024) to 14.8% (fiscal 2020); the current reading is higher than 33% of that period. That is above the Medical Devices industry median of −3.88% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 3.68% | 8.30 |
| FY2025 | −4.62% | 3.60 |
| FY2024 | −8.22% | (5.31) |
| FY2023 | −2.91% | (11.18) |
| FY2022 | 8.27% | (3.34) |
| FY2021 | 11.6% | (3.17) |
| FY2020 | 14.8% | 2.91 |
| FY2019 | 11.9% | (0.24) |
| FY2018 | 12.1% | (0.64) |
| FY2017 | 12.8% | 6.18 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 11.1% |
| AXGN AxoGen, Inc. compare | 7.50% |
| TMDX TransMedics Group, Inc. compare | 6.14% |
| NEOG Neogen Corporation | 5.64% |
| ITGR Integer Holdings Corporation compare | 4.48% |
| UFPT UFP Technologies, Inc. compare | 0.00% |
| ESTA Establishment Labs Holdings Inc. compare | −16.9% |
| BFLY Butterfly Network, Inc. compare | −22.4% |
| ALMR Alamar Biosciences, Inc. compare | −104.7% |
| Medical Devices industry median | −3.88% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement